ATEA PHARMACEUTICALS INC's ticker is AVIR and the CUSIP is 04683R106. A total of 70 filers reported holding ATEA PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 3.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,456,914 | -19.8% | 2,485,638 | 0.0% | 0.83% | -12.9% |
| Q2 2023 | $9,296,286 | +111540.3% | 2,485,638 | 0.0% | 0.96% | -8.1% |
| Q1 2023 | $8,327 | -30.4% | 2,485,638 | 0.0% | 1.04% | -22.1% |
| Q4 2022 | $11,956 | -99.9% | 2,485,638 | 0.0% | 1.34% | -20.9% |
| Q3 2022 | $14,143,000 | -19.9% | 2,485,638 | 0.0% | 1.69% | -18.5% |
| Q2 2022 | $17,648,000 | -1.7% | 2,485,638 | 0.0% | 2.07% | +18.8% |
| Q1 2022 | $17,946,000 | -19.2% | 2,485,638 | 0.0% | 1.74% | -1.1% |
| Q4 2021 | $22,222,000 | -82.9% | 2,485,638 | -32.8% | 1.76% | -78.1% |
| Q3 2021 | $129,722,000 | +7.5% | 3,700,000 | -34.1% | 8.05% | +1.8% |
| Q2 2021 | $120,624,000 | -65.2% | 5,615,659 | 0.0% | 7.90% | -59.8% |
| Q1 2021 | $346,767,000 | +47.8% | 5,615,659 | 0.0% | 19.64% | +33.4% |
| Q4 2020 | $234,622,000 | – | 5,615,659 | – | 14.73% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 2,485,638 | $22,222,000 | 1.76% |
| EcoR1 Capital, LLC | 5,376,134 | $48,063,000 | 1.53% |
| Cormorant Asset Management, LP | 1,679,442 | $15,014,000 | 0.89% |
| CM Management, LLC | 100,000 | $894,000 | 0.68% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 596,800 | $5,335,000 | 0.40% |
| PDT Partners, LLC | 278,487 | $2,490,000 | 0.19% |
| Ikarian Capital, LLC | 116,600 | $1,043,000 | 0.16% |
| HighVista Strategies LLC | 20,659 | $185,000 | 0.15% |
| Aristides Capital LLC | 35,132 | $314,000 | 0.14% |
| Parkwood LLC | 71,932 | $643,000 | 0.11% |